Log in
Enquire now

List of IDEAYA Biosciences patents

List of IDEAYA Biosciences patents
List of Amgen patents
List of sphingotec patents
List of Neogenomics patents
List of NCR patents
List of Ayla Networks patents
Patents where
Current Assignee
Name
is
IDEAYA BiosciencesIDEAYA Biosciences
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 11084798 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors

Patent 11084798 was granted and assigned to IDEAYA Biosciences on August, 2021 by the United States Patent and Trademark Office.

IDEAYA Biosciences
IDEAYA Biosciences
IDEAYA Biosciences
IDEAYA Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
11084798
August 10, 2021
‌
US Patent 11407764 AhR modulators

Patent 11407764 was granted and assigned to IDEAYA Biosciences on August, 2022 by the United States Patent and Trademark Office.

IDEAYA Biosciences
IDEAYA Biosciences
IDEAYA Biosciences
IDEAYA Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
11407764
August 9, 2022
‌
US Patent 11046691 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors

Patent 11046691 was granted and assigned to IDEAYA Biosciences on June, 2021 by the United States Patent and Trademark Office.

IDEAYA Biosciences
IDEAYA Biosciences
IDEAYA Biosciences
IDEAYA Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
11046691
June 29, 2021
‌
US Patent 10815250 AhR modulators

Patent 10815250 was granted and assigned to IDEAYA Biosciences on October, 2020 by the United States Patent and Trademark Office.

IDEAYA Biosciences
IDEAYA Biosciences
IDEAYA Biosciences
IDEAYA Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
10815250
October 27, 2020
‌
US Patent 11530220 Substituted imidazo[1,5-a]pyrazines and [1,2,4]triazolo[4,3-a]pyrazines for the modulation of AhR

Patent 11530220 was granted and assigned to IDEAYA Biosciences on December, 2022 by the United States Patent and Trademark Office.

IDEAYA Biosciences
IDEAYA Biosciences
IDEAYA Biosciences
IDEAYA Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
11530220
December 20, 2022
‌
US Patent 11584755 Dihydrothieno[3,2-b]pyridine compounds

IDEAYA Biosciences
IDEAYA Biosciences
IDEAYA Biosciences
IDEAYA Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
11584755
February 21, 2023
‌
US Patent 12115163 Combination therapy comprising a MAT2A inhibitor and a type II PRMT inhibitor

Patent 12115163 was granted and assigned to IDEAYA Biosciences on October, 2024 by the United States Patent and Trademark Office.

IDEAYA Biosciences
IDEAYA Biosciences
IDEAYA Biosciences
IDEAYA Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
12115163
October 15, 2024
7 results
0 selected
7 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us